Hallucinogen Use Disorder: Symptoms, Risks, and Treatment Options

Introduction

Hallucinogen use disorder is a condition that affects individuals who frequently use hallucinogenic substances, leading to significant mental, emotional, and physical health challenges. Hallucinogens are a class of drugs that cause profound changes in perception, mood, and thought, often resulting in visual or auditory hallucinations. While some people may use these substances recreationally, repeated use can lead to dependence and serious health complications. Hallucinogen use disorder has been recognized for decades, with substances like LSD, psilocybin (magic mushrooms), and MDMA (ecstasy) commonly associated with this condition. As telemedicine becomes a more accessible way to receive healthcare, understanding the risks, symptoms, and treatment options for those struggling with hallucinogen use disorder is essential. This article provides a comprehensive overview of the condition, including risk factors, symptoms, diagnostic tests, medications, procedures, and home-based strategies to manage symptoms.

Definition of Hallucinogen Use Disorder

Hallucinogen use disorder is characterized by the problematic use of hallucinogenic substances, leading to significant impairment or distress. This condition will be explored in terms of risk factors, symptoms, diagnostic tests, medications, procedures, and home-based strategies for managing symptoms.

Description of Hallucinogen Use Disorder

Hallucinogen use disorder occurs when an individual repeatedly uses hallucinogenic substances, such as LSD, psilocybin, or MDMA, to the point where it negatively impacts their daily life. Hallucinogens affect the brain’s serotonin system, which regulates mood, perception, and cognition. Over time, repeated use can lead to tolerance, meaning the person needs larger amounts of the substance to achieve the same effects. This increases the risk of overdose and other serious health complications.

The progression of hallucinogen use disorder varies depending on the individual, the substance used, and the frequency of use. Initially, individuals may use hallucinogens recreationally, but over time, they may develop cravings, experience withdrawal symptoms, and struggle to stop using the drug, even when it harms their relationships, work, or health. In severe cases, individuals may experience persistent psychosis or flashbacks, known as hallucinogen persisting perception disorder (HPPD).

According to the National Institute on Drug Abuse (NIDA), hallucinogen use disorder is relatively rare compared to other substance use disorders but still affects a significant number of people. In the United States, approximately 1.4 million people aged 12 or older reported using hallucinogens in the past month as of 2020. While not everyone who uses hallucinogens will develop a use disorder, those who do may face long-term mental health challenges if left untreated.

Risk Factors for Developing Hallucinogen Use Disorder

Lifestyle Risk Factors

Certain lifestyle choices can increase the risk of developing hallucinogen use disorder. Individuals who engage in frequent recreational drug use, particularly in social settings like parties or music festivals, may be more likely to experiment with hallucinogens. Peer pressure and the desire to fit in with a particular social group can also contribute to the initiation of hallucinogen use. Additionally, individuals who use other substances, such as alcohol or marijuana, may be more likely to try hallucinogens as part of a broader pattern of substance use. The availability of hallucinogens in certain environments, such as college campuses or urban nightlife scenes, can also increase the likelihood of use.

Medical Risk Factors

Several medical conditions may increase the risk of developing hallucinogen use disorder. Individuals with a history of mental health disorders, such as depression, anxiety, or schizophrenia, may be more susceptible to the negative effects of hallucinogens. Hallucinogens can exacerbate existing mental health conditions, leading to worsening symptoms and an increased risk of psychosis. Additionally, individuals with a history of substance use disorders, including alcohol or opioid dependence, may be more likely to develop a hallucinogen use disorder due to underlying patterns of addiction.

Genetic and Age-Related Risk Factors

Genetics can also play a role in the development of hallucinogen use disorder. Research suggests that individuals with a family history of substance use disorders may be more likely to develop similar conditions themselves. This genetic predisposition can make certain individuals more vulnerable to the effects of hallucinogens and increase their risk of developing a use disorder. Age is another important factor, as younger individuals, particularly those in their teens and early twenties, are more likely to experiment with hallucinogens. The developing brain is more susceptible to the effects of these substances, which can increase the risk of long-term cognitive and mental health issues.

Clinical Manifestations of Hallucinogen Use Disorder

Hallucinations (80-90%)

Hallucinations are one of the most common and defining symptoms of hallucinogen use disorder, occurring in 80-90% of cases. These are sensory experiences that appear real but are created by the mind. Individuals may see, hear, or feel things that are not actually present. Hallucinogens, such as LSD or psilocybin, disrupt the brain’s normal communication pathways by affecting serotonin, a neurotransmitter that regulates mood, perception, and cognition. This disruption can lead to vivid visual or auditory hallucinations. Hallucinations are more common during the acute phase of intoxication but can also occur during flashbacks, even long after the drug has been used.

Altered Perception of Reality (75-85%)

An altered perception of reality is another hallmark of hallucinogen use disorder, affecting 75-85% of individuals. This symptom involves a distorted sense of time, space, and self. People may feel like time is slowing down, speeding up, or that they are detached from their own body. Hallucinogens alter the brain’s ability to process sensory information, leading to these perceptual changes. This symptom is especially prominent during intoxication but can persist in some patients, contributing to ongoing psychological distress. It is often more severe in individuals who use hallucinogens frequently or in high doses.

Mood Swings (60-70%)

Mood swings are reported by 60-70% of individuals with hallucinogen use disorder. These rapid changes in mood can range from euphoria to intense sadness or anger. Hallucinogens affect the brain’s serotonin system, which plays a critical role in regulating mood. As a result, users may experience unpredictable emotional shifts. These mood swings are typically more pronounced during the acute phase of drug use but can also occur during withdrawal or in the context of flashbacks. The intensity of mood swings can vary depending on the specific hallucinogen used and the individual’s mental health history.

Anxiety (50-60%)

Anxiety is experienced by 50-60% of individuals with hallucinogen use disorder. Hallucinogens can cause intense feelings of fear or panic, especially if the user is in an unfamiliar or uncomfortable environment. The unpredictable nature of hallucinations and altered perceptions can also contribute to anxiety. This symptom is more common in individuals who have a pre-existing anxiety disorder or who use hallucinogens in high doses. Anxiety may occur during intoxication, but it can also persist in the form of flashbacks or post-use anxiety disorders.

Paranoia (40-50%)

Paranoia, or an irrational fear that others are trying to harm you, affects 40-50% of people with hallucinogen use disorder. This symptom is often linked to the distorted perceptions and hallucinations caused by the drug. Paranoia can be particularly distressing and may lead to dangerous behaviors, such as aggression or self-harm. It tends to be more common in individuals who use hallucinogens in high doses or who have a history of mental health disorders. Paranoia may occur during intoxication or persist in the form of delusional thinking after drug use has stopped.

Flashbacks (20-30%)

Flashbacks, also known as hallucinogen persisting perception disorder (HPPD), occur in 20-30% of individuals with hallucinogen use disorder. These are spontaneous recurrences of the drug’s effects, such as hallucinations or altered perceptions, long after the drug has been used. Flashbacks can be triggered by stress, fatigue, or substance use and can last for minutes to hours. Although the exact cause of flashbacks is not fully understood, it is believed that hallucinogens cause lasting changes in the brain’s serotonin system. Flashbacks can be distressing and may interfere with daily functioning.

Impaired Judgment (70-80%)

Impaired judgment is reported by 70-80% of individuals with hallucinogen use disorder. This symptom involves difficulty making sound decisions or recognizing the consequences of one’s actions. Hallucinogens disrupt the brain’s prefrontal cortex, which is responsible for decision-making and impulse control. As a result, users may engage in risky behaviors, such as driving under the influence or engaging in unsafe sexual practices. Impaired judgment is more common during intoxication but can also persist in individuals who use hallucinogens frequently or in high doses.

Disorientation (60-70%)

Disorientation, or confusion about time, place, or identity, affects 60-70% of individuals with hallucinogen use disorder. This symptom is caused by the drug’s effects on the brain’s ability to process sensory information and maintain a coherent sense of reality. Disorientation is most common during intoxication but can also occur during flashbacks or withdrawal. It can be particularly dangerous if the individual becomes confused about their surroundings and engages in risky behaviors.

Increased Heart Rate (30-40%)

Increased heart rate, or tachycardia, occurs in 30-40% of individuals with hallucinogen use disorder. Hallucinogens stimulate the sympathetic nervous system, which is responsible for the body’s “fight or flight” response. This can lead to an elevated heart rate, which may be accompanied by other physical symptoms such as sweating or dizziness. While increased heart rate is usually temporary, it can be dangerous for individuals with pre-existing heart conditions. This symptom is more common during the acute phase of intoxication.

Insomnia (40-50%)

Insomnia, or difficulty sleeping, affects 40-50% of individuals with hallucinogen use disorder. Hallucinogens can disrupt the brain’s normal sleep-wake cycle, leading to difficulty falling or staying asleep. Insomnia may occur during intoxication, withdrawal, or in the context of flashbacks. Chronic insomnia can contribute to other mental health issues, such as anxiety or depression, and may worsen the overall prognosis of hallucinogen use disorder.

Treatment Options for Hallucinogen Use Disorder

Medications for Hallucinogen Use Disorder

Naltrexone

Definition: Naltrexone works by blocking the effects of opioids and alcohol, binding to opioid receptors in the brain. It is primarily used to reduce cravings and prevent relapse in substance use disorders, and in some cases, it may be considered for hallucinogen use disorder.

How and When It’s Used: While naltrexone is typically prescribed for alcohol or opioid use disorder, it has been studied for hallucinogen addiction. It is most effective when combined with behavioral therapies and is generally used after detoxification. Although not a first-line treatment for hallucinogen use disorder, it may be considered in more complex cases involving cravings or co-occurring substance use.

Expected Outcomes: Patients may experience reduced cravings and a lower risk of relapse, with noticeable effects within a few weeks. The medication is often taken for several months to support long-term recovery.

Acamprosate

Definition: Acamprosate helps restore the balance of neurotransmitters in the brain that may be disrupted by long-term substance use. It is commonly used for alcohol use disorder and may also be considered for hallucinogen use disorder.

How and When It’s Used: Acamprosate is prescribed after detoxification. While primarily used for alcohol use disorder, it may be considered for hallucinogen use disorder to help stabilize brain chemistry. It is taken daily and is often combined with counseling or therapy.

Expected Outcomes: Patients may experience fewer withdrawal symptoms and improved mood stability, with effects becoming noticeable within the first few weeks.

Disulfiram

Definition: Disulfiram acts as a deterrent for alcohol consumption by causing unpleasant effects, such as nausea and vomiting, when alcohol is consumed. It is primarily used for alcohol use disorder.

How and When It’s Used: Disulfiram is not typically used for hallucinogen use disorder but may be prescribed if alcohol use is also a concern. It is usually reserved for patients with a history of relapse who need additional motivation to maintain sobriety.

Expected Outcomes: Patients can expect a reduced likelihood of drinking due to the negative physical reactions caused by the medication, with immediate effects if alcohol is consumed.

Olanzapine

Definition: Olanzapine is an antipsychotic medication used to manage symptoms of psychosis, such as hallucinations and delusions. It is often prescribed for schizophrenia and bipolar disorder but can also be used in cases of hallucinogen use disorder.

How and When It’s Used: Olanzapine may be prescribed if a patient experiences persistent psychotic symptoms due to hallucinogen use. It is taken orally and works by balancing dopamine and serotonin levels. This medication is typically used in severe cases where psychosis is present.

Expected Outcomes: Patients may experience a reduction in hallucinations and delusions within days to weeks, significantly improving quality of life in cases of severe hallucinogen-induced psychosis.

Quetiapine

Definition: Quetiapine is another antipsychotic medication used to treat schizophrenia, bipolar disorder, and major depressive disorder. It can also be used for hallucinogen-induced psychosis.

How and When It’s Used: Quetiapine is prescribed when a patient experiences severe mental health symptoms, such as hallucinations or paranoia, due to hallucinogen use. It works by altering neurotransmitter activity, particularly serotonin and dopamine. This medication is typically used in advanced cases.

Expected Outcomes: Patients can expect a reduction in psychotic symptoms within a few weeks, helping stabilize mood and improve mental health.

Sertraline

Definition: Sertraline is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression, anxiety, and other mood disorders. It may help manage mood disturbances caused by hallucinogen use.

How and When It’s Used: Sertraline is typically prescribed for patients experiencing depression or anxiety related to hallucinogen use. It is taken daily and often combined with therapy. While not a first-line treatment for hallucinogen use disorder, it may be used if mood disorders are present.

Expected Outcomes: Patients may notice improved mood and reduced anxiety within 4 to 6 weeks, helping stabilize emotions and reduce the risk of relapse.

Fluoxetine

Definition: Fluoxetine is another SSRI commonly used to treat depression, obsessive-compulsive disorder, and anxiety disorders. It can help manage mood symptoms associated with hallucinogen use.

How and When It’s Used: Fluoxetine is prescribed for patients struggling with mood disturbances, such as depression or anxiety, due to hallucinogen use. It is taken daily and works by increasing serotonin levels. It is often combined with counseling.

Expected Outcomes: Patients can expect improvements in mood and anxiety within 4 to 6 weeks, helping reduce emotional distress and support long-term recovery.

Gabapentin

Definition: Gabapentin is used to treat nerve pain, seizures, and certain mood disorders. It may also reduce cravings and withdrawal symptoms in substance use disorders.

How and When It’s Used: Gabapentin is sometimes prescribed to individuals recovering from hallucinogen use disorder, particularly if they experience withdrawal symptoms or cravings. It works by calming overactive nerves in the brain. It is not a first-line treatment but may be used in more complex cases.

Expected Outcomes: Patients may experience reduced cravings and withdrawal symptoms within a few days to weeks, making the recovery process more manageable.

Topiramate

Definition: Topiramate is used to treat seizures and prevent migraines. It has also been studied for its potential to reduce cravings in substance use disorders.

How and When It’s Used: Topiramate may be prescribed to individuals struggling with cravings or withdrawal symptoms related to hallucinogen use. It works by stabilizing brain activity and is typically used in complex cases where other treatments have not been effective.

Expected Outcomes: Patients may experience reduced cravings and improved mood stability within a few weeks, supporting long-term recovery.

Lamotrigine

Definition: Lamotrigine is a mood stabilizer and anticonvulsant used to treat bipolar disorder and epilepsy. It may also stabilize mood in individuals recovering from hallucinogen use disorder.

How and When It’s Used: Lamotrigine is prescribed for individuals experiencing mood instability, such as depression or mania, due to hallucinogen use. It works by reducing excessive brain activity and is typically used in advanced cases where mood disturbances are severe.

Expected Outcomes: Patients may experience improved mood stability within a few weeks to months, reducing the risk of relapse by stabilizing emotions.

Improving Hallucinogen Use Disorder and Seeking Medical Help

In addition to medications, several home remedies and lifestyle changes can help manage hallucinogen use disorder. These approaches complement medical treatment and support long-term recovery:

1. Meditation: Practicing mindfulness and meditation can reduce stress and improve mental clarity.
2. Exercise: Regular physical activity boosts mood and reduces cravings.
3. Healthy diet: A balanced diet supports brain health and recovery.
4. Adequate sleep: Proper rest is essential for emotional and physical recovery.
5. Support groups: Joining a support group provides emotional support and reduces feelings of isolation.
6. Journaling: Writing down thoughts and feelings helps process emotions and track progress.
7. Mindfulness practices: Being present and aware reduces anxiety and improves decision-making.
8. Avoiding triggers: Identifying and avoiding situations or people that trigger cravings is crucial for preventing relapse.
9. Stress management: Developing coping skills for stress reduces the likelihood of turning to substances as a coping mechanism.
10. Social support: Building a strong support network of friends and family provides encouragement and accountability.

Telemedicine offers a convenient way to seek medical help for hallucinogen use disorder. Through virtual appointments, patients can access professional care from the comfort of their homes, making it easier to stay on track with treatment and recovery.

Living with Hallucinogen Use Disorder: Tips for Better Quality of Life

Living with hallucinogen use disorder can be challenging, but there are steps you can take to improve your quality of life:

1. Stay connected with your healthcare provider through regular check-ins, whether in person or via telemedicine.
2. Engage in healthy coping mechanisms like exercise, meditation, and journaling to manage stress and cravings.
3. Build a strong support network of friends, family, and support groups to help you stay accountable.
4. Set realistic goals for your recovery and celebrate small victories along the way.
5. Stay informed about your condition and treatment options to make empowered decisions about your health.

Conclusion

Hallucinogen use disorder is a complex condition that can significantly impact mental and physical health. However, with the right combination of medical treatment, lifestyle changes, and support, recovery is possible. Early diagnosis and intervention are crucial for improving outcomes and preventing long-term complications. If you or someone you love is struggling with hallucinogen use disorder, our telemedicine practice is here to help. Contact us today to schedule a virtual consultation and take the first step toward recovery.

James Kingsley

Learn More